[HTML][HTML] Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape

J Gu, J Chen, S Xiang, X Zhou, J Li - Journal of Advanced Research, 2023 - Elsevier
Background Tripartite motif (TRIM) family proteins have more than 80 members and are
widely found in various eukaryotic cells. Most TRIM family proteins participate in the …

[HTML][HTML] Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung …

J Cui, Y He, F Zhu, W Gong, R Zuo… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Cisplatin is a first-line chemotherapy drug for lung adenocarcinoma (LUAD). However, its
therapeutic efficacy is limited because of serious side effects and acquired drug resistance …

Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin

Y Wang, T Zhang, H Du, M Yang, G Xie… - Oncology …, 2023 - spandidos-publications.com
Lung cancer accounts for the highest percentage of cancer morbidity and mortality
worldwide, and lung adenocarcinoma (LUAD) is the most prevalent subtype. Although …

TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization

H Qian, Z Lu, C Hao, Y Zhao, X Bo, Y Hu, Y Zhang… - Cellular …, 2023 - Elsevier
Myocardial infarction (MI) is one of the most dangerous cardiovascular events. Cardiac
fibrosis is a common pathological feature of remodeling after injury that is related to adverse …

Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.) GH Sungetal against lung adenocarcinoma

X Zhang, M Wang, X Liang, J Wang, M Zhang… - Journal of …, 2023 - Elsevier
Ethnopharmacological relevance Lung adenocarcinoma (LUAD) is one of the main types of
lung cancer. Ophiocordyceps sinensis has many potentially useful pharmacologic features …

An investigation of the molecular characterization of the tripartite motif (TRIM) family and primary validation of TRIM31 in gastric cancer

Y Ding, Y Lu, J Guo, S Chen, X Han, S Wang… - Human Genomics, 2024 - Springer
Most TRIM family members characterized by the E3-ubiquitin ligases, participate in
ubiquitination and tumorigenesis. While there is a dearth of a comprehensive investigation …

Identification of a Novel Prognostic Lymphangiogenesis‐Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma

J Peng, D Liu, H Zhang, Q Hu, W Chen… - Analytical Cellular …, 2024 - Wiley Online Library
Lymphangiogenesis, an integral contributor to lymphatic metastasis, is a significant reason
for the poor prognosis of cancer patients. Anti‐lymphangiogenesis treatment is a promising …

Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer

X Chen, Y Yu, Y Su, L Shi, S Xie, Y Hong, X Liu… - Functional & integrative …, 2024 - Springer
Chemotherapy resistance is the main reason for the poor prognosis of ovarian cancer (OC).
FHL1 is an important tumour regulator, but its relationship with the prognosis, drug …

Inhibiting miR-33b-5p Enhances Chemoresistance in Lung Adenocarcinoma by Targeting YWHAH to Regulate Epithelial-mesenchymal Transition

B Liu, ZY Pu, L Wang, J Fang, T Xue - Anticancer Research, 2023 - ar.iiarjournals.org
Background/Aim: Lung adenocarcinoma (LUAD) is the most malignant type of lung cancer,
whose clinical treatment is seriously hindered by chemoresistance. Numerous reports have …

[HTML][HTML] 高表达MYH9 通过激活AKT/c-Myc 通路抑制非小细胞肺癌细胞凋亡

刘芳, 彭岚竹, 席菁乐 - Journal of Southern Medical University, 2023 - ncbi.nlm.nih.gov
高表达MYH9通过激活AKT/c-Myc通路抑制非小细胞肺癌细胞凋亡- PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …